Stay updated on CPX-351 and Quizartinib in AML Clinical Trial

Sign up to get notified when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CPX-351 and Quizartinib in AML Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-10-03T05:30:20.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.11.0, while the previous version v2.10.5 has been removed, along with a notice regarding delays in displaying study record information.
    Difference
    4%
    Check dated 2024-09-25T23:09:32.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    ClinicalTrials.gov is addressing delays in displaying study record information, and the website has been updated to version 2.10.5, replacing the previous version 2.10.3.
    Difference
    4%
    Check dated 2024-09-18T17:12:48.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.2 to 2.10.3.
    Difference
    0.3%
    Check dated 2024-09-11T08:58:56.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.
    Difference
    0.3%
    Check dated 2024-08-14T00:28:12.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The website has been updated to version 2.10.0, introducing new features for viewing and comparing study record versions.
    Difference
    6%
    Check dated 2024-07-23T15:33:42.000Z thumbnail image

Stay in the know with updates to CPX-351 and Quizartinib in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CPX-351 and Quizartinib in AML Clinical Trial page.